Must be done by tonight at 1130 !!!! No plagiarism Write a 2- to 3-page paper
Case Study
Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
· glipizide 10 mg po daily
· HCTZ 25 mg daily
· atenolol 25 mg po daily
· hydralazine 25 mg qid
· simvastatin 80 mg daily
· verapamil 180 mg CD daily
· Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
· Review the case study assigned by your Instructor for this Assignment.
· Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
· Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
· Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
· Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
Cas
e
S
tudy
Patient
CB
has
a
hist
ory
of
strokes.
The
patient
has
been
diagnosed
with
type
2
diabetes,
hypertension,
and
hyperlipidemia.
Drugs
currently
prescribed
include
the
following:
·
glipizide
10
mg
po
daily
·
HCTZ
25
mg
daily
·
atenolol
25
mg
po
daily
·
hydralazine
25
mg
qid
·
simvastatin
80
mg
daily
·
verapamil
180
mg
CD
daily
·
Review the Resources for this module and consider the impact of potential
pharmacotherapeutics for cardiovascular disorders introduced in the media
piece.
·
Review the case study assigned by your Instructor for t
his Assignment.
·
Select one the following factors: genetics, gender, ethnicity, age, or behavior
factors.
·
Reflect on how the factor you selected might influence the patient’s
pharmacokinetic and pharmacodynamic processes.
·
Consider how changes in the pharmacokinetic and pharmacodynamic processes
might impact the patient’s recommended drug therapy.
·
Think about h
ow you might improve the patient’s drug therapy plan based on the
pharmacokinetic and pharmacodynamic changes. Reflect on whether you would
modify the current drug treatment or provide an alternative treatment option for
the patient.
Case Study
Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension,
and hyperlipidemia. Drugs currently prescribed include the following:
glipizide 10 mg po daily
HCTZ 25 mg daily
atenolol 25 mg po daily
hydralazine 25 mg qid
simvastatin 80 mg daily
verapamil 180 mg CD daily
Review the Resources for this module and consider the impact of potential
pharmacotherapeutics for cardiovascular disorders introduced in the media
piece.
Review the case study assigned by your Instructor for this Assignment.
Select one the following factors: genetics, gender, ethnicity, age, or behavior
factors.
Reflect on how the factor you selected might influence the patient’s
pharmacokinetic and pharmacodynamic processes.
Consider how changes in the pharmacokinetic and pharmacodynamic processes
might impact the patient’s recommended drug therapy.
Think about how you might improve the patient’s drug therapy plan based on the
pharmacokinetic and pharmacodynamic changes. Reflect on whether you would
modify the current drug treatment or provide an alternative treatment option for
the patient.